MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with F

Fluvastatin

Fluvastatin 20mg capsules

No stability information

Stability notes for Fluvastatin 20mg capsules

There are no stability notes for this medicine.

Suppliers (6) of Fluvastatin 20mg capsules
Fluvastatin 20mg capsules (A A H Pharmaceuticals Ltd)
Fluvastatin 20mg capsules (Alliance Healthcare (Distribution) Ltd)
Fluvastatin 20mg capsules (Medihealth (Northern) Ltd)
Fluvastatin 20mg capsules (Phoenix Healthcare Distribution Ltd)
Fluvastatin 20mg capsules (Sandoz Ltd)
Fluvastatin 20mg capsules (Teva UK Ltd)

Fluvastatin 40mg capsules

No stability information

Stability notes for Fluvastatin 40mg capsules

There are no stability notes for this medicine.

Suppliers (6) of Fluvastatin 40mg capsules
Fluvastatin 40mg capsules (A A H Pharmaceuticals Ltd)
Fluvastatin 40mg capsules (Alliance Healthcare (Distribution) Ltd)
Fluvastatin 40mg capsules (Medihealth (Northern) Ltd)
Fluvastatin 40mg capsules (Phoenix Healthcare Distribution Ltd)
Fluvastatin 40mg capsules (Sigma Pharmaceuticals Plc)
Fluvastatin 40mg capsules (Teva UK Ltd)

Fluvastatin 80mg modified-release tablets

No stability information

Stability notes for Fluvastatin 80mg modified-release tablets

There are no stability notes for this medicine.

Suppliers

Fluvastatin 80mg modified-release tablets (A A H Pharmaceuticals Ltd)
Fluvastatin 80mg modified-release tablets (Aspire Pharma Ltd)
Lescol XL 80mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.